GSK reported positive results from its phase three ‘DREAMM-7’ trial on Thursday, highlighting a significant overall survival ...

The federal government also has an agreement with vaccine manufacturer GSK for domestic vaccine production that could be accelerated if needed, the Public Health Agency of Canada told The Canadian ...

Full Year 2024 Guidance: 7% to 9% sales growth, 11% to 13% profit growth. GSK PLC (NYSE:GSK) reported a 9% sales growth and 19% profit growth year-to-date, reflecting strong performance in ...

GSK’s Meningococcal Group B Vaccine has been licensed in over 40 countries, including member states of the European Union, Argentina, Australia, Canada, Chile, Israel, New Zealand, Turkey ...

Lebanon's caretaker prime minister has said he hopes a ceasefire deal between Hezbollah and Israel will be announced "in the coming hours or days". Najib Mikati made the comments after speaking to ...

Welcome to today's call and webcast. The Q3 presentation was sent to our distribution list by e-mail and you can also find it on gsk.com. Please turn to Slide 2. This is the usual safe harbor ...

JERUSALEM – President Biden’s top Middle East advisers are scrambling to mediate a temporary cease-fire deal between Israel and the Lebanon-based terrorist movement Hezbollah that would ...

GSK cuts 2024 vaccine sales forecast for second ... Since November 2023, she has also been participating in Reuters coverage related to the Israel-Hamas war. Previously based in Nairobi and ...

Also Read: Just After Pfizer’s RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population Specialty Medicine sales increased ...

(Reuters) -GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, ...

LONDON — GSK’s once-booming vaccines business met new challenges in the third quarter, as the company lowered sales forecasts for vaccines for the year. Notably, quarterly sales of the ...

GlaxoSmithKline said its key brands held their market share and continued to stay in line with the respective category performance. GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 ...